← Back to Analyst Consensus 
QDEL Hold
QuidelOrtho Corp
Current Price —
Implied Upside —
Analysts 8
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 3, 2026 (8 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Jul 8, 2026 | Citigroup | maintain | Neutral → Neutral | — | 54% |
| Jul 1, 2026 | JP Morgan | maintain | Underweight → Underweight | — | 55% |
| May 7, 2026 | Jefferies | downgrade | Buy → Hold | — | 52% |
| May 6, 2026 | Citigroup | maintain | Neutral → Neutral | — | 54% |
| Apr 10, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Feb 12, 2026 | Citigroup | maintain | Neutral → Neutral | $30 | 54% |
| Jan 21, 2026 | UBS | maintain | Neutral → Neutral | $35 | 54% |
| Nov 7, 2025 | JP Morgan | maintain | Underweight → Underweight | $22 | 55% |
| Nov 6, 2025 | UBS | maintain | Neutral → Neutral | $31 | 54% |
| Oct 7, 2025 | Citigroup | downgrade | Buy → Neutral | $33 | 54% |
| Aug 7, 2025 | UBS | maintain | Neutral → Neutral | $26 | 54% |
| Aug 6, 2025 | Citigroup | maintain | Buy → Buy | $40 | 54% |
| May 8, 2025 | UBS | maintain | Neutral → Neutral | $29 | 54% |
| May 8, 2025 | Jefferies | upgrade | Hold → Buy | $44 | 52% |
| Apr 21, 2025 | JP Morgan | maintain | Underweight → Underweight | $25 | 55% |
| Feb 13, 2025 | RBC Capital | maintain | Outperform → Outperform | $61 | 55% |
| Feb 13, 2025 | UBS | maintain | Neutral → Neutral | $45 | 54% |
| Dec 11, 2024 | Citigroup | upgrade | Neutral → Buy | $50 | 54% |
| Dec 10, 2024 | Jefferies | initiate | — → Hold | $43 | 52% |
| Aug 16, 2024 | RBC Capital | reiterate | Outperform → Outperform | $61 | 55% |
| Aug 1, 2024 | RBC Capital | reiterate | Outperform → Outperform | $61 | 55% |
| May 9, 2024 | RBC Capital | maintain | Outperform → Outperform | $68 | 55% |
| Mar 4, 2024 | UBS | downgrade | Neutral → Sell | $42 | 54% |
| Feb 14, 2024 | Craig-Hallum | downgrade | Buy → Hold | $0 | 54% |
| Feb 14, 2024 | RBC Capital | maintain | Outperform → Outperform | $81 | 55% |
| Feb 14, 2024 | Raymond James | downgrade | Strong Buy → Outperform | $76 | 54% |
| Feb 14, 2024 | William Blair | downgrade | Outperform → Market Perform | $0 | 48% |
| Feb 14, 2024 | JP Morgan | downgrade | Neutral → Underweight | $37 | 55% |
| Dec 21, 2023 | RBC Capital | maintain | Outperform → Outperform | $130 | 55% |
| Dec 11, 2023 | Citigroup | downgrade | Buy → Neutral | $72 | 54% |
| Nov 2, 2023 | Raymond James | maintain | Strong Buy → Strong Buy | $100 | 54% |
| Sep 19, 2023 | RBC Capital | reiterate | Outperform → Outperform | $140 | 55% |
| Aug 15, 2023 | Raymond James | maintain | Strong Buy → Strong Buy | $110 | 54% |
| Aug 9, 2023 | JP Morgan | maintain | Neutral → Neutral | $85 | 55% |
| Aug 9, 2023 | RBC Capital | reiterate | Outperform → Outperform | $136 | 55% |
| May 4, 2023 | RBC Capital | maintain | — → Outperform | $133 | 55% |
| Feb 16, 2023 | RBC Capital | maintain | — → Outperform | $136 | 55% |
| Feb 16, 2023 | Raymond James | maintain | — → Strong Buy | $130 | 54% |
| Dec 12, 2022 | Citigroup | upgrade | Neutral → Buy | $125 | 54% |
| Dec 7, 2022 | RBC Capital | initiate | — → Outperform | $125 | 55% |
| Nov 3, 2022 | JP Morgan | maintain | — → Neutral | $93 | 55% |
| Oct 14, 2022 | UBS | upgrade | Sell → Neutral | $86 | 54% |
| Sep 19, 2022 | Citigroup | initiate | — → Neutral | $90 | 54% |
| Jul 20, 2022 | UBS | initiate | — → Sell | $86 | 54% |
Price Target Trend
Mar 31, 2026 Oct 26, 2026
EPS Estimates
+1y —
0q —
+1q —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days